Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07134777 · ClinicalTrials.gov registry record
Mechanisms of Visual Restoration After Occipital Stroke
A clinical trial of Stroke, Ischemic and Hemianopia, sponsored by University of Rochester.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07134777: Recruiting study of Stroke, Ischemic and Hemianopia, sponsored by University of Rochester.
NCT07134777 is a study of Stroke, Ischemic and Hemianopia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07134777, a study of Stroke, Ischemic and Hemianopia, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will collect brain imaging data to quantify the effects of early visual cortex damage and visual training interventions on the structure and function of the residual visual system. Our goal is to improve understanding of the consequences of permanent visual cortex damage in humans, and to understand how visual training impacts the function of the residual visual system to restore perception.
Primary Outcome
Use fMRI scans to identify areas of damage
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-17 |
| Est. Completion | 2029-08-01 |
What NCT07134777 shows while recruiting
NCT07134777 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 287-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (65% lower).
The record links to 7 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT07134777 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07134777 about?
NCT07134777 is a clinical study titled "Mechanisms of Visual Restoration After Occipital Stroke". This project will collect brain imaging data to quantify the effects of early visual cortex damage and visual training interventions on the structure and function of the residual visual system. Our goal is to improve understanding of the consequences of permanent visual cortex damage in humans, and ...
What is the current status of trial NCT07134777?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-10-17. Estimated completion is 2029-08-01.
What conditions does trial NCT07134777 study?
This clinical trial studies the following conditions: Stroke, Ischemic, Hemianopia, Cortical Blindness, Vision Loss Partial, Hemianopia Homonymous.
What interventions are being tested in trial NCT07134777?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07134777?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07134777 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07134777's enrollment target sits among peer trials
100 15th of 33 higher than 18 of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
RECRUITING
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RECRUITING
-
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
RECRUITING · Phase 1
-
Promoting Recovery After STroke With Amantadine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI